Colette Jackson

Dr. Colette Jackson is an Honorary Clinical Senior Lecturer at the University of Glasgow's School of Cardiovascular & Metabolic Health, Department of Cardiovascular & Medical Sciences. Her research focuses on heart failure, particularly biomarkers for diagnosis and prognosis, heart failure with preserved ejection fraction, and novel therapeutic approaches. She maintains an active research program with numerous publications in high-impact cardiology journals.

Dr. Jackson's research interests center on cardiovascular pathophysiology with specific emphasis on heart failure biomarkers, diagnostic approaches, and prognostic indicators. Her work explores urinary proteomics, inflammatory markers, and novel molecular pathways in heart failure. She has made significant contributions to understanding the role of interleukin-6, free light chains, and other biomarkers in predicting outcomes for heart failure patients. Her research bridges basic science with clinical applications, aiming to improve diagnostic accuracy and therapeutic decision-making.

Analysis of her recent publications reveals a strong focus on translational research with emphasis on biomarker discovery and validation. Her work spans from molecular pathophysiology to clinical trial design, with particular attention to heart failure with preserved ejection fraction and novel diagnostic approaches using urinary proteomics. The research demonstrates consistent progression from basic biomarker identification to clinical validation studies, with increasing focus on personalized medicine approaches in heart failure management.

Dr. Jackson has collaborated extensively with leading researchers at the University of Glasgow, including Professor John McMurray, Professor Roy Gardner, and Dr. Rachel Myles. Her work appears in top cardiology journals including Circulation: Heart Failure, European Heart Journal, and JACC: Heart Failure. Her research has contributed significantly to understanding risk stratification in heart failure and the development of novel diagnostic tools.